Sensei Biotherapeutics Inc (SNSE)

NASDAQ

$14.53

Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company, is dedicated to the discovery and development of therapies with an initial focus on cancer treatments. The company is headquartered in Rockville, Maryland.

Website: https://www.senseibio.com

Sector:

Healthcare

Industry:

Biotechnology

68 analysts

Buy

Target: $52.50 (+261.32%)

Market Cap

$19M

Beta (5Y)

1.16

Price Chart

Adjust inflation

Log

Valuation

Market Cap$19M

Profitability

Total Revenue (TTM)$1.24M

EBITDA-$186M

EPS-$138.28

Growth & Risk

FCF 5Y CAGR+4.98%

Beta (5Y)1.16

Sharpe Ratio0.98